The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.

Eli Lilly is continuing its Massachusetts shopping spree, picking up a Cambridge biotech focused on blood cancer treatments ...

Francesco Farioli appears to have ruled himself out of the running to manage Chelsea (Picture: sport tv) Francesco Farioli ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...

Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker's blood-cancer portfolio. Eli Lilly on Monday said Ajax is ...

Eli Lilly to acquire Ajax Therapeutics for up to $2.3B, boosting blood cancer pipeline with a Phase 1 JAK2 inhibitor for ...

Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer portfolio.

Eli Lilly said on Monday ​it would buy ​privately ​held blood cancer treatment developer Ajax Therapeutics for up to $2.3 ...

Earn these JavaScript certs to demonstrate mastery of the most in-demand skills for the world’s most-used programming ...